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Clostridium 
diffi cile in Retail 
Meat Products, 
USA, 2007 
J. Glenn Songer, Hien T. Trinh, 
George E. Killgore, Angela D. Thompson, 
L. Clifford McDonald, and Brandi M. Limbago
To determine the presence of Clostridium diffi cile, we 
sampled cooked and uncooked meat products sold in Tuc-
son, Arizona. Forty-two percent contained toxigenic C. dif-
fi cile strains (either ribotype 078/toxinotype V [73%] or 027/
toxinotype III [NAP1 or NAP1-related; 27%]). These fi ndings 
indicate that food products may play a role in interspecies 
C. diffi cile transmission. 
The incidence and severity of Clostridium diffi cile infec-tions (CDIs) are increasing in North America (1), prob-
ably because of emergence of an epidemic strain (NAP1/
BI/027, toxinotype [TT] III) (2,3). C. diffi cile transmission 
occurs primarily in healthcare facilities, but community-as-
sociated CDI (CA-CDI) appears to be increasing and may 
now account for 20%–45% of positive diagnostic assay 
results (4,5). Up to 35% of patients with CA-CDI report 
no antimicrobial agent use within 3 months before disease 
onset (4,5), although nonantimicrobial drugs (e.g., proton 
pump inhibitors, nonsteroidal antiinfl ammatory agents) are 
also implicated as risk factors (4). Sources of C. diffi cile 
acquisition in community settings are unknown.
CDI is increasingly important in food animals (6). In-
fection rates of >95% have been documented among neo-
natal pigs in farrowing facilities, resulting in diarrhea and 
typhlocolitis (6). Toxigenic C. diffi cile is also implicated as 
a cause of diarrhea in calves (7). C. diffi cile was identifi ed 
in raw meat intended for pet consumption (8) and in ≈20% 
of retail ground beef in Canada (9). We report the isolation 
of C. diffi cile from uncooked and ready-to-eat meats in re-
tail markets in a US metropolitan area.
The Study
Packaged meats were purchased from 3 national-chain 
grocery stores in the Tucson, Arizona, area on 3 occasions 
at 1-month intervals from January to April 2007. Prod-
ucts sampled were both uncooked (ground beef, ground 
pork, ground turkey, pork sausage, and pork chorizo) and 
ready to eat (beef summer sausage, pork braunschweiger) 
(Table). Pork chorizo was produced and distributed locally; 
all other samples were national brands. Products with dif-
ferent sell-by dates (a surrogate for production date) were 
sampled for each meat type. Samples were not representa-
tive of all meat products in each grocery store.
For each sample, 1 g of meat was added to two 10-
mL tubes of prereduced brain heart infusion (BD, Franklin 
Lakes, NJ, USA), which had been supplemented with 0.5% 
yeast extract (BD), 0.05% DL-cysteine (Sigma-Aldrich, St. 
Louis, MO, USA), and 0.1% taurocholate (MP Biomedi-
cals, Solon, OH, USA). One tube was heat shocked (80°C, 
10 min), and both were then incubated anaerobically at 
37°C for 72 h. Aliquots were subcultured onto taurocholate 
cycloserine cefoxitin fructose agar (TCCFA) (10) and in-
cubated anaerobically for 24–72 h at 37°C. Colonies were 
subcultured onto anaerobic blood agar, TCCFA (with or 
without antimicrobial agents), and confi rmed as C. diffi cile 
by p-cresol odor, yellow-green fl uorescence under UV il-
lumination, a positive L-proline aminopeptidase reaction, 
and negative indole reaction.
Isolates were characterized by PCR ribotyping (11), 
toxinotyping (3), and pulsed-fi eld gel electrophoresis 
(PFGE) (12). Presence of tcdA, tcdB, cdtB (binary toxin), 
and deletions in tcdC was determined by PCR (2).
MICs were determined by Etest (AB Biodisk, Solna, 
Sweden) on Brucella blood agar with vitamin K and hemin 
(Remel, Lenexa, KS, USA) that was incubated anaerobi-
cally at 35°C. Reference interpretive criteria for C. diffi cile 
susceptibility to clindamycin and moxifl oxacin were used; 
MICs for levofl oxacin and gatifl oxacin were interpreted 
by using criteria for moxifl oxacin (13). Bacteroides fra-
gilis ATCC 25285, B. thetaiotaomicron ATCC 29741, C. 
diffi cile ATCC 700057, and Enterococcus faecalis ATCC 
29212 were included as controls.
Proportions were compared by χ2 or Fisher exact test. 
Thirty-seven (42.0%) of 88 retail meats yielded C. diffi cile, 
including 42.4% of beef, 41.3% of pork, and 44.4% of tur-
key products (Table). Ready-to-eat products were more 
commonly culture positive (11/23; 47.8%) than were un-
cooked meats (26/65; 40.0%), although the difference was 
not signifi cant (p = 0.34). The highest percentages of C. 
diffi cile isolates were recovered from pork braunschweiger 
(62.5%) and ground beef (50.0%). Culture-positive results 
came from both heat-shocked and non–heat-shocked cul-
tures, whereas culture-negative specimens were negative 
in both types of culture, and no specimen was positive by 
both methods (not shown). No association was found with 
the meat processor, the sell-by date, the store, or the month 
sampled (not shown). Multiple independent cultures from 2 
braunschweiger samples yielded indistinguishable isolates 
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in the same meat sample (10/10 from 1 package and 12/12 
from another; not shown), which suggests that a single 
strain may predominate when C. diffi cile is present. Our 
percentage of recovery of C. diffi cile from retail meat prod-
ucts is higher than that reported (20%) in a similar study of 
Canadian ground beef (9), possibly because of differences 
in culture methods, the meats sampled, or national or geo-
graphic variation.
Isolates were grouped into ribotype 078/TT V (27/37, 
73.0%) and ribotype 027/TT III (10/37, 27.0%). Strain 
types were not specifi c to meat type, store, or sampling 
month (Table). All isolates were PCR positive for binary 
toxin (cdtB), tcdA, and tcdB. Characteristic 18-bp and 39-
bp deletions in tcdC were present in 027/TT III and 078/
TT V isolates, respectively (2,12). PFGE divided 027/ TT 
III isolates into NAP1 (>80% related to human NAP1) and 
NAP1-related (78% related to human NAP1) groups and 
078/TT V isolates into NAP7 and NAP8 groups (Figure).
Ribotype 027 isolates are described almost exclusively 
in context of the current human epidemic strain, NAP1/027/
TT III (2). In this study, we also found 027/TT III isolates 
that were only 78% similar to NAP1 (i.e., NAP1-related). 
Ribotype 078 strains were previously uncommon causes 
of healthcare-associated CDI in humans (12), but now 
they are emerging in pigs and calves with diarrhea (7; J.S. 
Weese, pers. comm.) and in persons with CDI (12). Two 
epidemiologically unrelated 078/TT V isolates from hu-
man CDI patients are indistinguishable by PFGE from pig 
isolates (12).
The 078/TT V isolates were uniformly susceptible to 
levofl oxacin, moxifl oxacin, and gatifl oxacin. Like human 
TT V isolates (12), most 078/TT V meat isolates were non-
susceptible to clindamycin (56% resistant, 41% intermedi-
ate). This may not be surprising given the widespread use 
of tylosin, erythromycin, virginiamycin, and lincomycin in 
food animals and the potential for selection of macrolide-
lincosamide-streptogramin resistance (14).
NAP1 isolates have demonstrated high-level resis-
tance to levofl oxacin, moxifl oxacin, gatifl oxacin (>32 μg/
mL), and clindamycin (>256 μg/mL), consistent with cur-
rent human strains (2). NAP1-related isolates were sus-
ceptible to levofl oxacin, moxifl oxacin, and gatifl oxacin 
but resistant to clindamycin, similar to the pattern of his-
toric NAP1 strains (2). 
Conclusions
Fluoroquinolones are widely used in human therapy, 
and the current epidemic strain may have emerged because 
of its resistance to these agents. Fluoroquinolone use is 
limited in food animal production (14), with the exception 
of enrofl oxacin for treatment of bovine respiratory disease 
(now approved for use in swine).
The source of C. diffi cile in retail meats may involve 
antemortem deposition of spores in the animal’s muscle or 
other tissues, fecal or environmental contamination of car-
casses, or contamination during processing. Spores could 
persist in packing plants, resulting in contamination of car-
casses or food products during processing. Contamination 
may also occur in retail meat markets.
Direct or indirect human-to-human transmission is re-
sponsible for most healthcare-related CDIs (15) and most 
likely contributes to CA-CDI. Therefore, stopping such 
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Table. Source and characteristics of Clostridium difficile isolates obtained from retail meats sold in Tuscon, Arizona, USA, 2007* 
Meat product No. samples 
cultured 
Total no. (%) 
positive  
Ribotype Toxinotype ?tcdC, bp† PFGE type No. (%) pos
Ground beef (uncooked) 26 13 (50) 027 III 18 NAP1 1 (3.8) 
      NAP1-related 2 (7.7) 
   078 V 39 NAP7 8 (30.8) 
      NAP8 2 (7.7) 
Summer sausage (ready to eat) 7 1 (14.3) 027 III 18 NAP1 1 (14.3) 
Ground pork (uncooked) 7 3 (42.9) 027 III 18 NAP1-related 1 (14.3) 
   078 V 39 NAP7 2 (28.6) 
Braunschweiger (ready to eat) 16 10 (62.5) 027 III 18 NAP1 2 (12.5) 
      NAP1-related 1 (6.2) 
   078 V 39 NAP7 7 (43.8) 
Chorizo (uncooked) 10 3 (30.0) 027 III 18 NAP1-related 1 (10.0) 
   078 V 39 NAP7 2 (20.0) 
Pork sausage (uncooked) 13 3 (23.1) 027 III 18 NAP1-related 1 (7.7) 
   078 V 39 NAP7 2 (15.4) 
Ground turkey (uncooked) 9 4 (44.4) 078 V 39 NAP7 4 (44.4) 
Totals 88 37 (42.0) 027 III 18 NAP1 4 (4.4) 
      NAP1-related 6 (6.7) 
   078 V 39 NAP7 25 (27.8)
      NAP8 2 (2.2) 
*All samples were positive for cdtB, which encodes the binding component of binary toxin. PFGE, pulsed-field gel electrophoresis. 
†Deletions in tcdC regulatory gene. 
C. diffi cile in Meat Products, USA
transmission remains the critical control point for prevent-
ing most human CDIs. Nonetheless, our fi ndings highlight 
the potential both for selection of virulent or resistant strains 
in animals and interspecies transmission through the food 
supply. Our data do not prove transmission of C. diffi cile 
from foods to humans but highlight the need for studies 
to characterize risks posed by this organism in the human 
food supply.
The study was partially supported by grant 2003-35204-
13786 from the US Department of Agriculture–Cooperative State 
Research, Education, and Extension Service–National Research 
Initiative.
Dr Songer is professor of Veterinary Science and Microbi-
ology at the University of Arizona. His research interests focus 
on bacterial diseases of food animals, mainly those affecting the 
gastrointestinal tract.
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Figure. Origin, NAP types, and relatedness of strains from foods 
and humans, Arizona, USA, 2007. All strains were positive by 
PCR for binary toxin. Scale bar indicates genetic relatedness. Tox, 
toxinotype; Ref, reference; NAP1-r, NAP1-related.
